Ultragenyx Pharmaceutical Inc.
NASDAQ-GS: RARE
.USD
+0.89 (4.08%)↑ today
Price at Feb 20, 4:00:01 PM EST • Market Closed
Loading...
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
2.19B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
0.54
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-3.90
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
568.00
Financial Performance
Revenue (TTM)
673.00M
Operating Cash Flow (TTM)
-466.00M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
-85.44%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-5.83
Cash
Total Cash (MRQ)
680.00M
Operating Free Cash Flow (TTM)
-466.00M
Levered Free Cash Flow (TTM)
-251.12M
Total Cash per Share (MRQ)
7.05
Advanced Valuations
Enterprise Value
2.68B
Enterprise Value to EBITDA
-5.37
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
3.26
Price-to-Book (MRQ)
140.49
Balance Sheet
Total Debt (MRQ)
1.25B
Debt to Equity (MRQ)
77.48
Current Ratio (MRQ)
2.48
Book Value per Share (MRQ)
-0.83
Detailed Financials
Revenue Growth (MRQ)
25.90%
Earnings Growth (YOY)
0.00%
Return on Equity (TTM)
-608.47%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
0.00%
Share Information
Shares Outstanding
96.48M
Shares Float
93.02M
Beta
0.16
52-Week Range
18.41 - 45.00
Trading & Ownership
Institutional Ownership
100.77%
Insider Ownership
3.13%
Short Interest
9.76%
Average 90-Day Volume
2.50M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Emil D. Kakkis
Founders
Dr. Emil D. Kakkis M.D., Ph.D.
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
1/5
As compared to these industry peers.
Loading...
Indicators
Founder-Operated
No
Founder-operated companies generally perform better.
CEO
Emil D. Kakkis
Founders
Dr. Emil D. Kakkis M.D., Ph.D.
Industry Safety Score
1/5
Biotechnology
Net Profitability Score
1/5
As compared to these industry peers.
Details
Valuations
Market Cap
Market Cap
Explainer
Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"
Related Articles
2.19B
PEG Ratio
PEG Ratio
Explainer
PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"
Related Articles
0.54
Trailing P/E Ratio
Trailing P/E Ratio
Explainer
Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"
Related Articles
-3.90
Forward P/E Ratio
Forward P/E Ratio
Explainer
Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"
Related Articles
568.00
Financial Performance
Revenue (TTM)
673.00M
Operating Cash Flow (TTM)
-466.00M
Net Profit Margin (TTM)
Net Profit Margin (TTM)
Explainer
Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"
Related Articles
-85.44%
Diluted EPS (TTM)
Diluted EPS (TTM)
Explainer
Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"
Related Articles
-5.83
Cash
Total Cash (MRQ)
680.00M
Operating Free Cash Flow (TTM)
-466.00M
Levered Free Cash Flow (TTM)
-251.12M
Total Cash per Share (MRQ)
7.05
Advanced Valuations
Enterprise Value
2.68B
Enterprise Value to EBITDA
-5.37
Price-to-Sales (TTM)
Price-to-Sales (TTM)
Explainer
Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"
Related Articles
3.26
Price-to-Book (MRQ)
140.49
Balance Sheet
Total Debt (MRQ)
1.25B
Debt to Equity (MRQ)
77.48
Current Ratio (MRQ)
2.48
Book Value per Share (MRQ)
-0.83
Detailed Financials
Revenue Growth (MRQ)
25.90%
Earnings Growth (YOY)
0.00%
Return on Equity (TTM)
-608.47%
Gross Profit Margin
Gross Profit Margin
Explainer
Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"
Related Articles
0.00%
Share Information
Shares Outstanding
96.48M
Shares Float
93.02M
Beta
0.16
52-Week Range
18.41 - 45.00
Trading & Ownership
Institutional Ownership
100.77%
Insider Ownership
3.13%
Short Interest
9.76%
Average 90-Day Volume
2.50M
Dividends
Payout Ratio
0.00%
Forward Dividend Yield
0.00%
Ex. Dividend Date
Unknown
Dividend Date
Unknown